What a doctor learned from taking psychedelic medicine | Anthony Back

Anthony Back, MD is Professor of Medicine at the University of Washington. His research into patient-oncologist communication led to the founding of VitalTalk, a 501c3 with the mission of disseminating communication skill training to doctors and nurses who care for patients with a serious illness and their families. In 2018, he turned his attention to psychedelic therapy, and has recently completed the first clinical trial of psilocybin-assisted therapy for doctors and nurses with symptoms of depression and burnout, his second study in psychedelic medicine is a study of group psilocybin-assisted therapy for patients with metastatic cancer.